SAN DIEGO, Nov. 11, 2011 /PRNewswire/ -- Organovo, Inc., a three dimensional biology company focused on bioprinting technology, today announced that Keith Murphy, Chairman and Chief Executive Officer, has been invited to present at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference. Mr. Murphy will present on Wednesday, November 16, 2011 at 1:30 p.m. EST. The conference will be held at The Pierre Hotel in New York City on November 15-16, 2011.
About Organovo, Inc.
Organovo is a three dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and surgical applications. The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types. Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine. Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic research, using technology that has the promise to also lead to creation of therapeutic tissues. Organovo technology leads the way in solving complex medical research problems with one overarching goal: to benefit the health and lives of patients. http://www.organovo.com
|SOURCE Organovo, Inc.|
Copyright©2010 PR Newswire.
All rights reserved